Cannabis, the Endocannabinoid System and Immunity—the Journey from the Bedside to the Bench and Back

O Almogi-Hazan, R Or - International journal of molecular sciences, 2020 - mdpi.com
The Cannabis plant contains numerous components, including cannabinoids and other
active molecules. The phyto-cannabinoid activity is mediated by the endocannabinoid …

Cannabis and autoimmunity: possible mechanisms of action

V Giorgi, D Marotto, A Batticciotto, F Atzeni… - ImmunoTargets and …, 2021 - Taylor & Francis
Medical cannabis (MC) describes the usually inhaled or ingested use of a cannabis plant or
cannabis extract for medicinal purposes. The action of whole cannabis plants is extremely …

Oral CBD-rich cannabis induces clinical but not endoscopic response in patients with Crohn's disease, a randomised controlled trial

T Naftali, L Bar-Lev Schleider, S Almog… - Journal of Crohn's …, 2021 - academic.oup.com
Aims Despite reports that medical cannabis improves symptoms in Crohn's disease [CD],
controlled studies evaluating disease response are lacking. This study assessed the effect of …

A systematic review with meta-analysis of the efficacy of cannabis and cannabinoids for inflammatory bowel disease: what can we learn from randomized and …

BH Doeve, MM Van De Meeberg… - Journal of Clinical …, 2021 - journals.lww.com
Results: The search identified 682 records of which 15 nonrandomized studies and 5
randomized controlled trials were eligible for inclusion. The meta-analysis of the primary …

The impact of cannabis use on clinical outcomes in inflammatory bowel disease: a population-based longitudinal cohort study

D Glickman, S Dalessio… - Inflammatory Bowel …, 2023 - academic.oup.com
Background Cannabis use is common in inflammatory bowel disease (IBD). Recent studies
demonstrated that use of cannabis may relieve symptoms; however, it is still unclear how …

Changes in MMP‑2, MMP‑9, inflammation, blood coagulation and intestinal mucosal permeability in patients with active ulcerative colitis

X Bai, G Bai, L Tang, L Liu, Y Li… - Experimental and …, 2020 - spandidos-publications.com
Abstract Changes in matrix metalloproteinase (MMP)-2, MMP-9, inflammation, blood
coagulation factors and intestinal mucosal permeability in patients with active ulcerative …

An overview of cannabis based treatment in Crohn's disease

T Naftali - Expert Review of Gastroenterology & Hepatology, 2020 - Taylor & Francis
Introduction: Cannabis use among inflammatory bowel disease (IBD) patients is common.
There are many studies of various laboratory models demonstrating the anti–inflammatory …

Cannabis and canabidinoids on the inflammatory bowel diseases: going beyond misuse

ACA Carvalho, GA Souza, SV Marqui… - International Journal of …, 2020 - mdpi.com
Inflammatory bowel diseases (IBD) are characterized by a chronic and recurrent
gastrointestinal condition, including mainly ulcerative colitis (UC) and Crohn's disease (CD) …

Cannabis and the gastrointestinal tract

L Cohen, MG Neuman - Journal of Pharmacy & …, 2020 - journals.library.ualberta.ca
Cannabis has been used for its medicinal purposes since ancient times. Its consumption
leads to the activation of Cannabis receptors CB1 and CB2 that, through specific …

[PDF][PDF] 复方苦参汤联合美沙拉嗪对溃疡性结肠炎治疗效果及炎性因子水平的影响

喻婷, 胡德胜, 楚思, 刘星星, 范恒 - 现代生物医学进展, 2021 - biomed.cnjournals.com
摘要目的: 探讨复方苦参汤联合美沙拉嗪对溃疡性结肠炎治疗效果及炎性因子水平的影响. 方法:
以我院2017 年1 月至2019 年12 月中西医结合科和消化内科收治的206 例溃疡性结肠炎患者为 …